WARRANT AGENCY AGREEMENTWarrant Agency Agreement • November 8th, 2019 • Yield10 Bioscience, Inc. • Miscellaneous plastics products • New York
WARRANT AGENCY AGREEMENT, dated as of [ ], 2019 (“Agreement”), between Yield10 Bioscience, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company (the “Warrant Agent”).
SHARES OF COMMON STOCK _____ SHARES OF SERIES A CONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO _______ SHARES OF COMMON STOCK), WARRANTS EXERCISABLE INTO _______ SHARES OF COMMON STOCK OF YIELD10 BIOSCIENCE, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 8th, 2019 • Yield10 Bioscience, Inc. • Miscellaneous plastics products • New York
SERIES [A][B] COMMON STOCK PURCHASE WARRANTYield10 Bioscience, Inc. • November 8th, 2019 • Miscellaneous plastics products • New York
THIS SERIES [A][B] COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, CEDE & CO. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Authorized Share Increase Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______ 1 2 . (the “Termination Date”) but not thereafter, to subscribe for and purchase from Yield10 Bioscience, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this W
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 8th, 2019 • Yield10 Bioscience, Inc. • Miscellaneous plastics products • Delaware
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) dated November __, 2019, is entered into by and among (i) Yield10 Bioscience, Inc., a Delaware corporation (the “Company”), and (ii) each person listed on Schedule I hereto (each, an “Investor” and collectively, the “Investors”).
